The EU is concerned about subsidies granted by non-EU countries to businesses active in the EU that could distort competition in EU markets.
The Foreign Subsidies Regulation (FSR) establishes a new suspensory notification...more
The EU is concerned about subsidies granted by non-EU countries to businesses active in the EU, that could distort competition in EU markets.
The Foreign Subsidies Regulation (FSR) establishes a new regime, enforced by the...more
The European Commission (EC) and the UK Competition and Markets Authority (CMA) have published new guidance on the assessment of cooperation between competitors. For the EU, this is contained in revised Guidelines on...more
9/13/2023
/ Acquisitions ,
Antitrust Provisions ,
Competition ,
EU ,
Horizontal Agreements ,
Information Sharing ,
Mergers ,
New Guidance ,
Regulatory Agenda ,
UK ,
UK Competition and Markets Authority (CMA)
The second annual report on the functioning of the UK’s investment screening regime has been published. We highlight the key points....more
The UK government has published a much-anticipated Bill which will make significant changes to the UK competition and consumer rules and bolster the powers of the Competition and Markets Authority (CMA). Revised merger...more
The UK government has published a much-anticipated Bill to shake up the competition and consumer regime. Front and centre is a brand new UK digital markets regime. The new rules aim to boost competition in the digital sector...more
2022 saw a mixed picture in terms of antitrust enforcement across the globe. For the jurisdictions surveyed in our report, global fine totals were down significantly from 2021 (USD3.5bn, compared to USD11.3bn), with the U.S.,...more
Nearly a year after the UK Competition and Markets Authority (CMA) announced its Sustainability Taskforce, it has issued for consultation draft guidance to show how businesses can pursue green cooperation without fear of...more
On 20 October 2022, an adviser (Advocate General) to the European Court of Justice (ECJ) recommended that the ECJ uphold the European Commission (EC)’s appeal of a 2020 judgment by the lower-tier General Court (GC), which set...more
The UK’s new national security screening tool has been in force for over 9 months and its impact on deal making is being felt. Determining whether notification is required can be complex and while the notification process...more
The UK Competition and Markets Authority (CMA) has reimposed fines on Pfizer and Flynn Pharma for abusing their dominant positions by charging excessive and unfair prices for phenytoin, an anti-epilepsy drug. ...more
The UK National Security and Investment Act 2021 (NSIA) has been in force for over six months. We know that within the first three months, the UK government received 221 notifications and “called-in” 17 deals for a more...more
This newsletter is a summary of the antitrust developments we think are most interesting to your business. Thomas Masterman, partner based in London, is our editor this month (learn more about Tom in our Q&A feature at the...more
UK competition rules are facing unprecedented levels of change. Last month we reported on the UK Government’s intentions for broad reforms to the competition and consumer law regimes. Now, the Government has set out the...more
Following a consultation in summer 2021, which set out a suite of wide-ranging proposals for reforms to UK competition and consumer laws, the UK Government has now confirmed the changes that it plans to take forward.
...more
The UK Competition and Markets Authority (CMA) has published for consultation its much-anticipated draft guidance on vertical agreements (Draft Guidance). ...more
The UK Competition and Markets Authority (CMA) has imposed over GBP260 million in fines on several drug makers for two breaches of competition law: (i) charging excessive and unfair prices, in breach of the Chapter II...more
Public input -
As we wrote a couple of months ago, antitrust authorities of the US, Canada, UK, and EU formed, in March, an international working group: the Multilateral Pharmaceutical Merger Task Force (the Task Force)....more
Working group’s goal is “concrete and actionable” updates to pharmaceutical merger analysis....more
On 26 November 2020, the European Commission (Commission) issued a decision fining pharmaceutical companies Teva and Cephalon EUR60.5 million for infringing Article 101 TFEU by agreeing to delay the entry of a cheaper generic...more